Acta Ophthalmol

1. VUJOSEVIC S, Kaderli ST, Piccoli G, Tagliabue E, et al
   Inter-eye microvascular asymmetry across stages of diabetic retinopathy: An OCT angiography study.
   Acta Ophthalmol. 2026 Jul 30. doi: 10.1111/aos.70202.
   

   >> Share

   
   

   
   Am J Cardiol

2. HAFEZ A, Mahmoud AK, Awad K, Mohamed MR, et al
   GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Hypertrophic Cardiomyopathy with Type 2 Diabetes: A Propensity Score-Matched Real-World Analysis.
   Am J Cardiol. 2026 Jul 29:S0002-9149(26)00482.
   

   >> Share

   
   

   
   Diabet Med

3. NALEER SM
   Diabetic eye screening is working-Just not for the patients who need it most.
   Diabet Med. 2026 Jul 27:e70438. doi: 10.1111/dme.70438.
   

   >> Share

   
   
4. BRITTEN FL, Shipton E, Duke M, Duncan EL, et al
   A systematic review of breastfeeding prevalence, duration and determining factors in women with type 1 and type 2 diabetes mellitus.
   Diabet Med. 2026 Jul 28:e70315. doi: 10.1111/dme.70315.
   

   >> Share

   
   
5. PATTON SR, Monzon AD, Redel J, O'Donnell H, et al
   Fear of hypoglycaemia and parent sleep disturbance in families of young children with type 1 diabetes.
   Diabet Med. 2026 Jul 31:e70441. doi: 10.1111/dme.70441.
   

   >> Share

   
   
6. WINTERDIJK P, Aanstoot HJ, Fransman C, Mocan A, et al
   Embedding psychological care in diabetes services: Why it's time to innovate and integrate.
   Diabet Med. 2026 Jul 30:e70411. doi: 10.1111/dme.70411.
   

   >> Share

   
   
7. ATHANASIADOU KI, Pavlou P, Qureshi A, Brackenridge A, et al
   Immune checkpoint inhibitor-induced diabetes mellitus: A case series from a large tertiary centre in the UK.
   Diabet Med. 2026 Jul 28:e70439. doi: 10.1111/dme.70439.
   

   >> Share

   
   
8. ESPENHEIN M, Pals RAS, Cleal B, Gronbaek HN, et al
   Participants' experiences of a co-adapted group-based intervention to reduce diabetes distress in people with type 2 diabetes attending municipal rehabilitation services.
   Diabet Med. 2026 Jul 29:e70440. doi: 10.1111/dme.70440.
   

   >> Share

   
   

   
   Diabetes

9. ZHANG J, Li M, Zhou X, Ni H, et al
   Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization.
   Diabetes. 2026 Jul 31:db260365. doi: 10.2337/db26-0365.
   

   >> Share

   
   
10. YUAN D, Wang K, Ping F, Li H, et al
    SIRT6 Deficiency Impairs Endothelial Integrity to Exacerbate Diabetic Atherosclerosis via Inhibiting Deacetylation-Dependent ZEB1 Degradation.
    Diabetes. 2026 Jul 28:db251059. doi: 10.2337/db25-1059.
    

    >> Share

    
    

    
    Diabetes Care

11. FEODOROFF M, Makimattila S, Thorn LM, Groop PH, et al
    Fracture Risk Is Increased in Type 1 Diabetes and Is the Highest in Individuals With Diabetic Kidney Disease.
    Diabetes Care. 2026 Jul 27:dc260612. doi: 10.2337/dc26-0612.
    

    >> Share

    
    
12. MILBOURN VEL, Barn R, Tieges Z, Hurst J, et al
    Emergency Hospitalization, Amputation, and Survival After Charcot Neuro-Osteoarthropathy Diagnosis in People With Diabetes: A Regional Registry-Based Cohort Study.
    Diabetes Care. 2026 Jul 28:dc260373. doi: 10.2337/dc26-0373.
    

    >> Share

    
    
13. SHAH BR, Odugbemi T, Li Z, Stewart C, et al
    In Utero Exposure to Preexisting or Gestational Diabetes Mellitus Increases Incidence of Diabetes in the Children of First Nations and Non-First Nations Mothers: A Retrospective Cohort Study.
    Diabetes Care. 2026 Jul 31:dc260710. doi: 10.2337/dc26-0710.
    

    >> Share

    
    
14. NORMAHANI P, Burgess L, Graham C, Norrie J, et al
    Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes (DMPAD): A Multicenter Comparative Diagnostic Accuracy Study.
    Diabetes Care. 2026 Jul 29:dc251693. doi: 10.2337/dc25-1693.
    

    >> Share

    
    
15. KLEMANN C, Kordonouri O
    Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes.
    Diabetes Care. 2026 Jul 28:dc260543. doi: 10.2337/dc26-0543.
    

    >> Share

    
    

    
    Diabetes Obes Metab

16. RODBARD HW, Irace C, Lobo J, Makrilakis K, et al
    Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE).
    Diabetes Obes Metab. 2026 Jul 26. doi: 10.1111/dom.71132.
    

    >> Share

    
    
17. PIGSBORG K, Kienle SM, Wretlind A, Rotbain Curovic V, et al
    Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.
    Diabetes Obes Metab. 2026 Jul 28. doi: 10.1111/dom.71130.
    

    >> Share

    
    
18. SCHAARUP JR, Bjerg L, Hansen CS, Witte DR, et al
    Cardiovascular Autonomic Neuropathy and Indices of Heart Failure in Type 2 Diabetes: The CANCAN Study.
    Diabetes Obes Metab. 2026 Jul 28. doi: 10.1111/dom.71100.
    

    >> Share

    
    
19. YU A, Whitfield K, Hale A, D'Emden M, et al
    Economic Impact of Multidisciplinary Pre-operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non-cardiac Surgery in Australia: A Trial-Based Analysis.
    Diabetes Obes Metab. 2026 Jul 28. doi: 10.1111/dom.71139.
    

    >> Share

    
    
20. TANG H, Zhang B, Lu Y, Zhou T, et al
    GLP-1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation.
    Diabetes Obes Metab. 2026 Jul 28. doi: 10.1111/dom.71142.
    

    >> Share

    
    
21. AMIOKA M, Amioka H, Kinoshita H, Sairaku A, et al
    Low-Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non-Diabetic Japanese Adults.
    Diabetes Obes Metab. 2026 Jul 28. doi: 10.1111/dom.71162.
    

    >> Share

    
    
22. ZHANG X, Ren A, Liang K, Chen J, et al
    Islet-Resident Macrophages as Dynamic Immunometabolic Integrators of beta-Cell Fate in Health and Diabetes.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71154.
    

    >> Share

    
    
23. SILVERII GA, Velardi V, Marinelli C, Lax A, et al
    Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71128.
    

    >> Share

    
    
24. SVEHLIKOVA E, Gatschelhofer C, Lackner B, Ratzer M, et al
    A New Highly Concentrated Insulin Aspart AT278 (500 U/mL) Demonstrates Ultra-Rapid Pharmacokinetic and Pharmacodynamic Properties in Type 2 Diabetes Regardless of BMI.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71150.
    

    >> Share

    
    
25. BEERNINK JM, Laverman GD, Heerspink HJL
    Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71147.
    

    >> Share

    
    
26. COSSON E, Emery C, Torreton E, Detournay B, et al
    Economic Burden of Type 1 Diabetes in France.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71103.
    

    >> Share

    
    
27. MORENO-PEREZ O, Tejera-Munoz A, Tomas-Gomez P, Vazquez-San Miguel F, et al
    Real-World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study (MEDFINE-RWD).
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71160.
    

    >> Share

    
    
28. CYRANKA K, Matejko B, Susul K, Sudul P, et al
    Beyond Glycaemia: Fear of Hypoglycaemia, Cognition and Functional Mobility After Advanced Hybrid Closed-Loop Therapy in Older Adults With Type 1 Diabetes: A Prespecified Secondary Analysis of a Randomised, Single-Centre Study.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71170.
    

    >> Share

    
    
29. AL-THANI NM, Toor SM, Umlai UI, Aliyu U, et al
    Refining the Genetic Contribution to Type 2 Diabetes Subtypes.
    Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71159.
    

    >> Share

    
    
30. SWABY R, Townson J, Besser REJ
    A UK Healthcare Professional Perspective on the Implementation of Monitoring in Children and Young People With Early-Stage Type 1 Diabetes: A Qualitative Study.
    Diabetes Obes Metab. 2026 Jul 26. doi: 10.1111/dom.71141.
    

    >> Share

    
    
31. EISA N, Khoury M, Barood O
    Diagnostic Yield of Structured Cushing Syndrome Evaluation in Treatment-Resistant Non-Diabetic Obesity: A Retrospective Pilot Study.
    Diabetes Obes Metab. 2026 Jul 26. doi: 10.1111/dom.71161.
    

    >> Share

    
    
32. BABIR FJ, Marcotte-Chenard A, Sandilands RE, Falkenhain K, et al
    Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non-Insulin Treated Type 2 Diabetes: A Randomised Trial.
    Diabetes Obes Metab. 2026 Jul 25. doi: 10.1111/dom.71052.
    

    >> Share

    
    

    
    Diabetologia

33. AIELLO E, Grieco GE, Brunetti M, Gliozzo G, et al
    Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages.
    Diabetologia. 2026;69:2620-2633.
    

    >> Share

    
    
34. SAPONARO C, Imbernon M, Louvet I, Deligia E, et al
    Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion.
    Diabetologia. 2026;69:2534-2553.
    

    >> Share

    
    
35. STANISZEWSKA A, Jones A, Davies L, Game F, et al
    Development of a core descriptor set for studies assessing interventions for diabetes-related foot ulceration.
    Diabetologia. 2026 Jul 25. doi: 10.1007/s00125-026-06815.
    

    >> Share

    
    
36. XI Y, Thorand B, Schneider A, Wolf K, et al
    Association of long-term exposure to air pollution, built environment and air temperature with the incidence of prediabetes phenotypes, and prediabetes remission and progression to type 2 diabetes: a longitudinal study in the KORA cohort.
    Diabetologia. 2026 Jul 25. doi: 10.1007/s00125-026-06814.
    

    >> Share

    
    
37. MORI T, Herder C, Cardoso P, Dennis JM, et al
    Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches.
    Diabetologia. 2026 Jul 25. doi: 10.1007/s00125-026-06802.
    

    >> Share

    
    
38. VIPLE F, Pedersen SS, Andersen TH, Raben A, et al
    Effects of time-restricted eating on markers of glucose metabolism and regulation in individuals with prediabetes or type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
    Diabetologia. 2026 Jul 27. doi: 10.1007/s00125-026-06792.
    

    >> Share

    
    
39. BERG J, Cherry P, Cheung K, Horava S, et al
    Understanding MASLD and diabetes through lived experience.
    Diabetologia. 2026 Jul 29. doi: 10.1007/s00125-026-06808.
    

    >> Share

    
    
40. KONSTANTARA E, Lindgreen P, Kuriakose L, Zaremba N, et al
    A narrative systematic review of definitions and diagnostic criteria for disordered eating and eating disorders in type 1 diabetes.
    Diabetologia. 2026 Jul 29. doi: 10.1007/s00125-026-06805.
    

    >> Share

    
    
41. SOE KK, Robinson E, Oleolo M, Goonoo M, et al
    Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study.
    Diabetologia. 2026 Jul 29. doi: 10.1007/s00125-026-06818.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

42. REGURAM R, Shah R, Vora T, Arsene C, et al
    Insulin Pump Use and Hospital Outcomes in Adults With Type 1 Diabetes: A 2022 Nationwide Readmissions Database Analysis.
    J Clin Endocrinol Metab. 2026 Jul 30:dgag307. doi: 10.1210.
    

    >> Share

    
    

    
    J Nutr

43. TORRES-LAITON L, Balcerzak W, Zamora R, Gasque A, et al
    The Association of Diabetes-related Dietary Patterns with Pancreatic Cancer Risk in the European Prospective Investigation into Cancer and Nutrition study.
    J Nutr. 2026 Jul 25:101755. doi: 10.1016/j.tjnut.2026.101755.
    

    >> Share

    
    

    
    Lancet

44. MORA P, Aroda VR, Asong M, Bluher M, et al
    Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
    Lancet. 2026 Jul 30:S0140-6736(26)01247-X. doi: 10.1016/S0140-6736(26)01247.
    

    >> Share

    
    
45. MORA P, Aroda VR, Asong M, Bluher M, et al
    Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
    Lancet. 2026 Jul 30:S0140-6736(26)01248-1. doi: 10.1016/S0140-6736(26)01248.
    

    >> Share

    
    

    
    Metabolism

46. DENG K, Li-Gao R
    Reply to letter to the editor: From metabolic subtypes to preventive decisions in high-risk type 2 diabetes.
    Metabolism. 2026 Jul 29:156719. doi: 10.1016/j.metabol.2026.156719.
    

    >> Share

    
    
47. CHEN Y, Zhang Y, Yu F, Ni Y, et al
    From metabolic subtypes to preventive decisions in high-risk type 2 diabetes.
    Metabolism. 2026 Jul 30:156718. doi: 10.1016/j.metabol.2026.156718.
    

    >> Share

    
    
48. YANG L, Wang Y, Wang D, Zhang L, et al
    Reduction of PDZK1 promotes diabetic kidney disease by modulating fatty acid uptake in proximal tubular epithelial cells.
    Metabolism. 2026 Jul 31:156720. doi: 10.1016/j.metabol.2026.156720.
    

    >> Share

    
    

    
    Ophthalmology

49. PATEL SV, Benetz BA, Price MO, Reed ZW, et al
    Factors Associated with Endothelial Cell Density at One Year in the Diabetes Endothelial Keratoplasty Study.
    Ophthalmology. 2026 Jul 30:S0161-6420(26)00531.
    

    >> Share

    
    
50. PRICE MO, Szczotka-Flynn LB, Reed ZW, Gal RL, et al
    Factors Associated with Successful Descemet membrane endothelial keratoplasty in the Diabetes Endothelial Keratoplasty Study.
    Ophthalmology. 2026 Jul 28:S0161-6420(26)00526.
    

    >> Share

    
    

    
    PLoS One

51. ABAS MZ, Mohd Zaidi NA, Lee PJ, Teh XR, et al
    The quality of care for type 2 diabetes mellitus management in Malaysian primary health care settings: A scoping review of ABC (glycated haemoglobin A1c, blood pressure, and LDL-cholesterol).
    PLoS One. 2026;21:e0355227.
    

    >> Share

    
    
52. AZIZ F, Malek S, Firdhaus Arham A, Yaacob M, et al
    Predicting medication non-adherence using machine learning: Incorporating Complementary and Alternative Medicine (CAM) beliefs in Malaysian chronic disease patients.
    PLoS One. 2026;21:e0354682.
    

    >> Share

    
    
53. ZHU W, Wu X, Hu R
    Leveraging expression quantitative trait loci information in single-cell resolution to identify cell-specific genes for gestational diabetes.
    PLoS One. 2026;21:e0355339.
    

    >> Share

    
    
54. MWENDA-NG'UNI N, Heine M, Goma F, Martens M, et al
    Educational strategies to improve health literacy for people with type 2 diabetes in low socio-economic communities: A realist review protocol.
    PLoS One. 2026;21:e0352599.
    

    >> Share

    
    
55. PHONYIAM R, Srichalerm T, Sawatpanich A, Keawpugdee J, et al
    Social determinants of health and postnatal wellbeing among women with type 2 diabetes in Thailand: An explanatory sequential mixed-methods study protocol.
    PLoS One. 2026;21:e0354735.
    

    >> Share

    
    
56. JANBOZORGI M, Taheri A, Hosseinzadeh M, Ghafaripur S, et al
    Pilot study: The effect of eight weeks of aerobic training in the two phases of light and dark circadian rhythm on genes (OCT4, NANOG, SOX2, REX1) in bone tissue of diabetic mice.
    PLoS One. 2026;21:e0353987.
    

    >> Share

    
    
57. ALARCON-YAQUETTO DE, Stewart R, Ismail K, Shearer J, et al
    The economic burden of Type 2 Diabetes by social determinants of health: A systematic review.
    PLoS One. 2026;21:e0354198.
    

    >> Share

    
    
58. ELADEL A, Filali I, Zaied M
    Artificial intelligence for early detection of diabetic retinopathy: A vision transformer-based approach.
    PLoS One. 2026;21:e0350854.
    

    >> Share

    
    

    
    Retina

59. BADDAR D, Fouad Y, Salem NO, Feo A, et al
    Type 4 macular neovascularization in eyes with diabetic retinopathy.
    Retina. 2026 Jul 30. doi: 10.1097/IAE.0000000000004948.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share